← back to search

Olaf Stüve

Southwestern Medical Center · US
Area of research
Pathology and Forensic Medicine · Immunology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Polyomavirus and related diseases, and Immunotherapy and Immune Responses.
h-index
71
citations
21,404
works
374
NIH funding
primary concept
email

Recent publications

Lipoic Acid for Treatment of Progressive Multiple Sclerosis
Neurology 2025cited by 3position: middledoi
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials
The Lancet Neurology 2024cited by 66position: middledoi
A review of Bruton’s tyrosine kinase inhibitors in multiple sclerosis
Therapeutic Advances in Neurological Disorders 2024cited by 23position: middledoi
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome
Annals of Neurology 2022cited by 129position: middledoi
Toward Precision Phenotyping of Multiple Sclerosis
Neurology Neuroimmunology & Neuroinflammation 2022cited by 83position: middledoi
Disease-modifying therapy prescription patterns in people with multiple sclerosis by age
Therapeutic Advances in Neurological Disorders 2021cited by 19position: lastdoi
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trials
Therapeutic Advances in Neurological Disorders 2020cited by 40position: lastdoi
Evolution of clinical trials in multiple sclerosis
Therapeutic Advances in Neurological Disorders 2019cited by 61position: lastdoi
MAdCAM-1-Mediated Intestinal Lymphocyte Homing Is Critical for the Development of Active Experimental Autoimmune Encephalomyelitis
Frontiers in Immunology 2019cited by 33position: lastdoi
Clinical trials in multiple sclerosis: potential future trial designs
Therapeutic Advances in Neurological Disorders 2019cited by 15position: lastdoi
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis
Annals of Neurology 2018cited by 55position: middledoi
Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models
Journal of the American Society of Nephrology 2018cited by 32position: middledoi
Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn’s Disease: Report of the TOSCA Study
Journal of Crohn s and Colitis 2017cited by 28position: lastdoi
Unintended pregnancies occurring during clinical trials for multiple sclerosis therapeutics (P1.363)
Neurology 2017cited by 1position: lastdoi
Effect of Template Reporting of Brain MRIs for Multiple Sclerosis on Report Thoroughness and Neurologist-Rated Quality: Results of a Prospective Quality Improvement Project
Journal of the American College of Radiology 2016cited by 58position: middledoi
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Multiple Sclerosis Journal 2015cited by 503position: middledoi
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Multiple Sclerosis Journal 2015cited by 398position: middledoi
Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder
JAMA Neurology 2015cited by 62position: middledoi
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis
Multiple Sclerosis Journal 2014cited by 192position: middledoi
High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Cell Transplantation for Relapsing-Remitting Multiple Sclerosis (HALT-MS)
JAMA Neurology 2014cited by 178position: middledoi
A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis
Multiple Sclerosis Journal 2014cited by 158position: middledoi
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis
Multiple Sclerosis Journal 2014cited by 129position: lastdoi
A systematic review of the incidence and prevalence of cancer in multiple sclerosis
Multiple Sclerosis Journal 2014cited by 106position: middledoi
Immunophenotyping of Cerebrospinal Fluid Cells in Multiple Sclerosis
JAMA Neurology 2014cited by 69position: middledoi
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Multiple Sclerosis Journal 2014cited by 58position: lastdoi
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review
Multiple Sclerosis Journal 2014cited by 55position: middledoi
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis
Nature Reviews Neurology 2013cited by 223position: middledoi
Treatment of neuromyelitis optica: Review and recommendations
Multiple Sclerosis and Related Disorders 2012cited by 262position: middledoi
Effect of glatiramer acetate on disease reactivation in <scp>MS</scp> patients discontinuing natalizumab
European Journal of Neurology 2012cited by 41position: middledoi
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation
Multiple Sclerosis Journal 2012cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gary Cutter · Epilepsy Foundation15 papers (2012–2021)Jeffrey A. Cohen · Cleveland Clinic8 papers (2014–2016)Stephen C. Reingold · Brampton Civic Hospital7 papers (2014–2015)Per Soelberg Sørensen · University of Copenhagen7 papers (2014–2015)María Trojano · University of Bari Aldo Moro7 papers (2014–2015)Nadia Reider · Manitoba Health7 papers (2014–2015)Yinan Zhang · University of Alabama at Birmingham4 papers (2019–2021)Amber Salter · Southwestern Medical Center4 papers (2019–2021)Heinz Wiendl · JDSU (United States)3 papers (2014–2024)Benjamin M. Segal · Hebrew University of Jerusalem3 papers (2016–2019)Mitchell T. Wallin · University of Maryland, Baltimore3 papers (2020–2025)Laura Airas · Turku University Hospital2 papers (2022–2024) · 2 papers (2012–2012) · 2 papers (2012–2012)Hans‐Peter Hartung · The University of Sydney2 papers (2019–2024)Douglas L. Arnold · Montreal Neurological Institute and Hospital2 papers (2014–2024)William J. Culpepper · University of Maryland, Baltimore2 papers (2020–2021)John R. Rinker · University of Alabama at Birmingham2 papers (2016–2025)Afsaneh Shirani · Southwestern Medical Center2 papers (2017–2020)Silvia Rossi · University of Padua2 papers (2012–2012)